VLADIMIR HUGEC M.D. NPI 1790723328

NPI Information

  • NPI: 1790723328
  • Provider Name: VLADIMIR HUGEC, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1580 BEAM AVE
    MAPLEWOOD, MN
    ZIP 55109
  • Phone: (651) 779-7978

Map and Directions

Get Directions

NPI Details

Vladimir Hugec, M.D. is a hematology and oncology internal medicine in Maplewood, MN with 32 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Vladimir Hugec, M.D. NPI is 1790723328. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

1580 BEAM AVE
MAPLEWOOD, MN
ZIP 55109-127
Phone: (651) 779-7978
Fax: (651) 779-7656

The NPI 1790723328 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, aprepitant, 1 mg (HCPCS:J0185)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, docetaxel, 1 mg (HCPCS:J9171)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Piflufolastat f-18, diagnostic, 1 millicurie (HCPCS:A9595)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Unclassified drugs (HCPCS:J3490)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Application of on-body injector for under skin injection (HCPCS:96377)
  • Measurement of immunoglobulin light chains (HCPCS:83521)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Protein measurement, serum (HCPCS:84165)
  • Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
  • Magnesium level (HCPCS:83735)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Urinalysis, manual test (HCPCS:81002)
  • Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Red blood count automated, with additional calculations (HCPCS:85046)
  • Blood creatinine level (HCPCS:82565)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Uric acid level, blood (HCPCS:84550)
  • Administration of chemotherapy into vein using push technique (HCPCS:96409)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Ct scan of soft tissue of neck with contrast (HCPCS:70491)

The enumeration date for this NPI number is 6/4/2006 and was last updated on 11/30/2017.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology48469MINNESOTAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1133107OTHERMINNESOTAUCARE MN
21047206OTHERMINNESOTAPREFERREDONE
334860300MEDICAIDWISCONSIN
4830000461MEDICARE ID-TYPE UNSPECIFIEDMINNESOTAMEDICARE
5227945200MEDICAIDMINNESOTA
63600658OTHERMINNESOTAMEDICA
7P00320622MEDICARE ID-TYPE UNSPECIFIEDMINNESOTARAILROAD MEDICARE
8HP65744OTHERMINNESOTAHEALTHPARTNERS
92443520OTHERMINNESOTAAMERICA'S PPO
10H78198MEDICARE UPIN
11110H1HUOTHERMINNESOTABLUE CROSS BLUE SHIELD

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.